Abacavir lamivudine labels and packages: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Abacavir lamivudine}} {{CMG}}; {{AE}} {{SS}} ==Labels And Packages== {| |- |thumb|850px|left |- |}<ref name="dailymed.nlm.nih.g...")
 
No edit summary
 
Line 6: Line 6:
{|
{|
|-
|-
|[[File:Abacavir lamivudine 8.jpg|thumb|850px|left]]
|[[File:Abacavir lamivudine 7.jpg|thumb|850px|left]]
|-
|-
|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1139e7f-2db9-4961-9da3-9b7f2088736f#section-11.3 | publisher =  | date =  | accessdate = 10 January 2014 }}</ref>
|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1139e7f-2db9-4961-9da3-9b7f2088736f#section-11.3 | publisher =  | date =  | accessdate = 10 January 2014 }}</ref>

Latest revision as of 01:51, 10 January 2014

Abacavir lamivudine
EPZICOM ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels And Packages

[1]

References

  1. "EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]". Retrieved 10 January 2014.

Adapted from the FDA Package Insert.